Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: current status and future prospects
Visceral leishmaniasis (VL) is a vector-borne chronic infectious disease caused by the protozoan parasite Leishmania donovani or Leishmania infantum. VL is a serious public health problem, causing high morbidity and mortality in the developing world with an estimated 0.2 -0.4 million new cases each...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2014-06-01
|
| Seri Bilgileri: | Frontiers in Immunology |
| Konular: | |
| Online Erişim: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00296/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|